IPO registrations (S-1, F-1) · Registrants
Conexeu Sciences Inc.
- SEC CIK
- 2066836 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2025-11-28, last 2026-04-17; 1 initial registration, 6 amendments
- Outcome
- Final prospectus filed 2026-05-11; declared effective 2026-05-11
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 3842
- Incorporated in
- NV
- Business address
- 50 WEST LIBERTY STREET, SUITE 880, Reno, NV 89501
- Ticker
- CNXU (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Conexeu Sciences Inc. on the corporate pages
Offering terms
- Final price
- $2.00 per share (424B4 filed 2026-05-11, an initial public offering)
- Shares sold
- 9,481,123
- Gross proceeds
- $18,962,246 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CNXU
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CONEXEU SCIENCES INC. Fuzzy (name and state)
- Form D issuer: Conexeu Sciences Inc. EXACT (CIK (EXACT))
- SEC filer: Conexeu Sciences Inc. EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2025-11-28 | S-1 | S-1 (registration) | Conexeu Sciences Inc. | 0001062993-25-017070 ↗ |
| 2026-02-03 | S-1/A | S-1/A (amendment) | Conexeu Sciences Inc. | 0001062993-26-000578 ↗ |
| 2026-03-05 | S-1/A | S-1/A (amendment) | Conexeu Sciences Inc. | 0001062993-26-001297 ↗ |
| 2026-03-26 | S-1/A | S-1/A (amendment) | Conexeu Sciences Inc. | 0001062993-26-001640 ↗ |
| 2026-04-06 | S-1/A | S-1/A (amendment) | Conexeu Sciences Inc. | 0001062993-26-001871 ↗ |
| 2026-04-10 | S-1/A | S-1/A (amendment) | Conexeu Sciences Inc. | 0001062993-26-001914 ↗ |
| 2026-04-17 | S-1/A | S-1/A (amendment) | Conexeu Sciences Inc. | 0001062993-26-002041 ↗ |
| 2026-05-11 | 424B4 | 424B4 (final prospectus) | Conexeu Sciences Inc. | 0001062993-26-002473 ↗ |
| 2026-05-11 | EFFECT | EFFECT (declared effective) | Conexeu Sciences Inc. | 9999999995-26-001569 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | S-1/A | registration statement | $2.00 | 9,481,123 | $18,962,246 | Nasdaq CNXU | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ | |
| 2026-05-11 | 424B4 | final prospectus | $2.00 | 9,481,123 | $18,962,246 | Nasdaq CNXU | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bogart David Robert | Director; Director,Officer | Chief Commercial Officer | 2 | 2026 | |
| Chavez-Munoz Claudia Itze | Officer | Chief Science Officer | 1 | 2026 | |
| Farberg Aaron Solomon | Director | 1 | 2026 | ||
| Harrison Miles David | Director,Officer | President and CEO | 1 | 2026 | |
| Inouye Stephen Douglas | Officer | CFO, Secretary, and Treasurer | 1 | 2026 | |
| Lorenc Zbigniew Paul | Director | 2 | 2026 | ||
| OnePointTwo Capital Ventures II LLC | TenPercentOwner | 1 | 2026 | ||
| OnePointTwo Capital Ventures LLC | TenPercentOwner | 2 | 2026 | ||
| Pilcher Brian Keith | Officer | Chief Medical Officer | 1 | 2026 | |
| Purcell Lynn Sebastian | Director,TenPercentOwner | 5 | 2026 | ||
| Sharpe Jeffrey Nathan | Director | 3 | 2026 | ||
| Wright Michael G. | TenPercentOwner | 3 | 2026 | ||
| Bastiani-Posner Ana Lucia | Director | 1 | 2026 | ||
| Burke April Lynn | Director | 1 | 2026 | ||
| Costa Andrew | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-09-29 | Conexeu Sciences Inc. | Biotechnology | $30,875 | $30,875 | 2 | 1 |
| 2026-09-15 | Conexeu Sciences Inc. | Biotechnology | $252,148 | $252,148 | 2 | 1 |
| 2026-08-31 | Conexeu Sciences Inc. | Biotechnology | $88,548 | $88,548 | 3 | 1 |
| 2026-07-31 | Conexeu Sciences Inc. | Biotechnology | $62,725 | $62,725 | 2 | 1 |
| 2026-06-30 | Conexeu Sciences Inc. | Biotechnology | $465,953 | $203 | 1 | 1 |
| 2026-06-30 | Conexeu Sciences Inc. | Biotechnology | $86,320 | $86,320 | 2 | 1 |
| 2026-06-10 | Conexeu Sciences Inc. | Biotechnology | $137,427 | $22,905 | 1 | 1 |
| 2026-05-21 | Conexeu Sciences Inc. | Biotechnology | $44,700 | $44,700 | 1 | 1 |
| 2026-05-21 | Conexeu Sciences Inc. | Biotechnology | $1,248,634 | $543 | 3 | 1 |
| 2026-04-01 | Conexeu Sciences Inc. | Biotechnology | $1,815,000 | $1,815,000 | 8 | 1 |
| 2026-03-23 | Conexeu Sciences Inc. | Biotechnology | $44,698 | $44,698 | 1 | 1 |
| 2026-02-27 | Conexeu Sciences Inc. | Biotechnology | $1,072,437 | $467 | 7 | 1 |
| 2026-02-04 | Conexeu Sciences Inc. | Biotechnology | $810,000 | $810,000 | 1 | 1 |
| 2025-11-20 | Conexeu Sciences Inc. | Biotechnology | $202,299 | $202,299 | 7 | 1 |
| 2025-11-13 | Conexeu Sciences Inc. | Biotechnology | $2,921,446 | $2,921,446 | 5 | 1 |
| 2025-06-13 | Conexeu Sciences Inc. | Biotechnology | $2,200 | $1,700 | 3 | 2 |
| 2025-05-09 | Conexeu Sciences Inc. | Biotechnology | $2,531,964 | $1,287,329 | 18 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CONEXEU SCIENCES INC. | NV | State business registries | name and state |
| Form D issuer | Conexeu Sciences Inc. | NV | Form D private offerings | CIK (EXACT) |
| SEC filer | Conexeu Sciences Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Conexeu Sciences Inc. | NV | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Orthopedic, Prosthetic & Surgical Appliances & Supplies, NV first:
- United Health Products, Inc. NV
- MEDICOR LTD NV
- RORINE INTERNATIONAL HOLDING Corp NV
- INNOVASIVE DEVICES INC MA
- CARDIOPULMONARY CORP CT
- DEPUY INC IN
- CARDIMA INC CA
- ANIMAS CORP PA
- INTUITIVE SURGICAL INC CA
- GOLD ENTERPRISE GROUP INC FL
In other datasets, the same topic (Technology) in NV:
- Form D issuer: 01 Labs, Inc. (Form D private offerings)
- Lobbying client: ADCOM TECHNOLOGIES LLC (Federal lobbying (LDA))
Interests: Orthopedic, Prosthetic & Surgical Appliances & Supplies · Technology